Kestra Medical Technologies, Ltd.
KMTS
$24.83
-$0.38-1.51%
NASDAQ
| 10/31/2025 | 07/31/2025 | 04/30/2025 | 01/31/2025 | 10/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -132.17M | -119.76M | -113.81M | -84.05M | -84.16M |
| Total Depreciation and Amortization | 8.13M | 7.62M | 7.97M | 9.63M | 11.11M |
| Total Amortization of Deferred Charges | 1.48M | 1.67M | 1.40M | 1.23M | 1.26M |
| Total Other Non-Cash Items | 44.48M | 35.99M | 34.20M | 6.02M | 5.86M |
| Change in Net Operating Assets | -8.61M | -11.93M | -7.39M | -1.73M | -374.00K |
| Cash from Operations | -86.70M | -86.41M | -77.64M | -68.89M | -66.30M |
| Capital Expenditure | -27.88M | -25.00M | -23.79M | -19.95M | -20.85M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 400.00K | 524.00K | 510.00K | 269.00K | 272.00K |
| Cash from Investing | -27.48M | -24.48M | -23.28M | -19.68M | -20.58M |
| Total Debt Issued | -- | -- | -- | 0.00 | 0.00 |
| Total Debt Repaid | -- | -- | -- | 0.00 | 0.00 |
| Issuance of Common Stock | 218.16M | 218.16M | 218.16M | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | 0.00 | 0.00 | 103.40M | 115.90M | 128.40M |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -5.48M | -6.03M | 8.70M | 11.90M | 11.41M |
| Cash from Financing | 212.68M | 212.13M | 330.26M | 127.80M | 139.81M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 98.51M | 101.25M | 229.35M | 39.23M | 52.93M |